Assessing Metabolic and Sleep Consequences of Overnight Home Parenteral Nutrition
NCT04743960 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2025-09-25
Summary
The purpose of this study is to determine whether advancing the timing of home parenteral nutrition from overnight to daytime regimens leads to improved glucose profiles and sleep quality, and other changes in plasma metabolic signatures.
Conditions
- Feeding Patterns
- Sleep
- Glucose Intolerance
- Short Bowel Syndrome
Interventions
- DIETARY_SUPPLEMENT
-
Time-of-day of parenteral nutrition provision
Parenteral nutrition will be provided during the nighttime followed by daytime.
Sponsors & Collaborators
-
ASPEN Rhoads Research Foundation
collaborator INDUSTRY -
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Hassan S Dashti, Ph.D., R.D. · Massachusetts General Hospital
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 79 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-05
- Primary Completion
- 2022-10-24
- Completion
- 2022-10-24
Countries
- United States
Study Locations
More Related Trials
-
Clinical Study on Circadian Genes Dysregulation in Patients With Glucocorticoid Disorders
NCT04374721 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Modafinil to Counteract the Adverse Metabolic Consequences of Sleep Restriction
NCT00895570 ·Status: COMPLETED ·Phase: NA
-
Collecting Information About Treatment Results for Patients With Cushing's Syndrome
NCT03364803 ·Status: RECRUITING
-
Evaluation Of Striatal Glucose Metabolism With Positron Emission Tomography Following PF-02545920 In Healthy Subjects
NCT01103726 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Apathy in Glycemic Control
NCT00844090 ·Status: COMPLETED ·Phase: NA
-
To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.
NCT00426608 ·Status: COMPLETED ·Phase: PHASE1
-
Reducing Antipsychotic-Induced Weight Gain in Children With Metformin
NCT01231074 ·Status: COMPLETED ·Phase: PHASE1
-
Heart Rate Variability in Response to Metformin Challenge
NCT02500628 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes
NCT01281228 ·Status: COMPLETED ·Phase: NA
-
Effects of Metyrapone in Patients With Hypercortisolism
NCT05255900 ·Status: COMPLETED
-
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
NCT01825798 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Consequences of Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie Intake
NCT06556277 ·Status: COMPLETED ·Phase: NA
-
Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth
NCT00617240 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time
NCT00809536 ·Status: TERMINATED ·Phase: PHASE1
-
An Insulin Sensitivity Study in Healthy Subjects
NCT02922426 ·Status: COMPLETED ·Phase: PHASE1
-
Circadian Clocks and Eating Patterns (Cohort)
NCT04642534 ·Status: COMPLETED
-
The Effects of Antipsychotic Drugs on Brain Metabolism in Healthy Individuals
NCT02536846 ·Status: COMPLETED ·Phase: PHASE4
-
Determining Metabolic Effects of Valproate and Antipsychotic Therapy
NCT00167934 ·Status: COMPLETED ·Phase: NA
-
Metabolic Effects of Antipsychotics in Children
NCT00205699 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy
NCT00677313 ·Status: COMPLETED ·Phase: NA
-
Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness
NCT02167620 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Metabolic State on Anxiety in Human Subjects
NCT01322243 ·Status: TERMINATED ·Phase: NA
-
Glucose Tolerance, Meal Timing and MTNR1B
NCT03003936 ·Status: COMPLETED ·Phase: NA
-
Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes
NCT05193578 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
NCT07104812 ·Status: RECRUITING ·Phase: PHASE2